The therapeutic efficacy of leukocyte boosting injection and leukocyte boosting drug needs to be evaluated according to the patient’s sensitivity to drug treatment, the presence of obvious toxic side effects and other factors, and it is not possible to give a clear standard. White-boosting injection, i.e. recombinant human granulocyte colony-stimulating factor, is used to increase the number of white blood cells in the body by stimulating bone marrow hematopoietic cells to maintain human immunity, and is used for patients with lowered white blood cell counts caused by a variety of etiologies, such as tumors, severe aplastic anemia and other patients. Leukocyte-boosting drugs: including Lixisheng, Shark Liver Alcohol Tablets, Diyu Lianbai Tablets and other drugs, mainly used in the treatment of leukopenia, thrombocytopenia, immunocompromise, aplastic anemia and other diseases of patients. It has the effect of protecting the hematopoietic system, elevating peripheral leukocytes, neutrophils and platelets, improving skeletal microcirculation, and regulating and improving body immunity. In clinical work, patients need to choose the appropriate therapeutic drugs under the guidance of specialists, not to use drugs privately to avoid adverse reactions.